Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-01-05 Sale | 2024-01-08 6:14 pm | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 5,994 | $10.79 | $64,656 | 107,503 (Direct) | View |
2023-12-11 Sale | 2023-12-11 8:00 pm | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 886 | $9.1301 | $8,089 | 1,997 (Direct) | View |
2022-12-12 Sale(A) | 2022-12-23 8:00 pm | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 887 | $6.01 | $5,331 | 2,883 (Direct) | View |
2022-12-12 Sale | 2022-12-14 8:00 pm | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 887 | $6.01 | $5,331 | 2,883 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-01-05 Option Award | 2024-01-08 6:14 pm | N/A 2034-01-04 | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 80,000 | $0 | 107,503 (Direct) | View |
2024-01-05 Exercise | 2024-01-08 6:14 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 10,500 | $0 | 107,503 (Direct) | View |
2023-12-11 Exercise | 2023-12-11 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 1,550 | $0 | 1,997 (Direct) | View |
2023-01-05 Option Award | 2023-01-06 8:00 pm | N/A 2033-01-04 | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 78,500 | $0 | 78,500 (Direct) | View |
2022-12-12 Exercise(A) | 2022-12-23 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 1,550 | $0 | 2,883 (Direct) | View |
2022-12-12 Exercise | 2022-12-14 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 1,550 | $0 | 2,883 (Direct) | View |
2022-03-10 Option Award | 2022-03-11 9:00 pm | N/A 2032-03-09 | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
Ownership | 2022-03-04 9:20 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 0 | $0 | 21,020 (Direct) | View |